391 related articles for article (PubMed ID: 17381632)
1. Bovine hemoglobin (glutamer-250, Hemopure)-specific immunoglobulin G antibody cross-reacts with human hemoglobin but does not lyse red blood cells in vitro.
Hamilton RG; Kickler TS
Transfusion; 2007 Apr; 47(4):723-8. PubMed ID: 17381632
[TBL] [Abstract][Full Text] [Related]
2. A pair of naturally occurring antibodies may dampen complement-dependent phagocytosis of red cells with a positive antiglobulin test in healthy blood donors.
Alaia V; Frey BM; Siderow A; Stammler P; Kradolfer M; Lutz HU
Vox Sang; 2009 Nov; 97(4):338-47. PubMed ID: 19570063
[TBL] [Abstract][Full Text] [Related]
3. Measuring circulating blood volume using infused hemoglobin-based oxygen carrier (oxyglobin) as an indicator: verification in a canine hypovolemia model.
Jahr JS; Lurie F; Bezdikian V; Driessen B; Gunther RA
Am J Ther; 2008; 15(2):98-101. PubMed ID: 18356627
[TBL] [Abstract][Full Text] [Related]
4. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
5. Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination.
Brain MC; Ruether B; Valentine K; Brown C; ter Keurs H
Transfusion; 2010 Feb; 50(2):292-301. PubMed ID: 19843291
[TBL] [Abstract][Full Text] [Related]
6. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects.
Hughes GS; Francome SF; Antal EJ; Adams WJ; Locker PK; Yancey EP; Jacobs EE
J Lab Clin Med; 1995 Nov; 126(5):444-51. PubMed ID: 7595029
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
9. Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis.
Kurlander RJ; Rosse WF; Logue GL
J Clin Invest; 1978 May; 61(5):1309-19. PubMed ID: 96137
[TBL] [Abstract][Full Text] [Related]
10. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score = 27-41).
Dudkiewicz M; Harpaul TA; Proctor KG
Crit Care Med; 2008 Oct; 36(10):2838-48. PubMed ID: 18766094
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity patterns of IgM and IgG anti-lipopolysaccharide antibodies in individual mice.
Di Pauli R
Eur J Immunol; 1975 Oct; 5(10):689-94. PubMed ID: 11993336
[TBL] [Abstract][Full Text] [Related]
13. Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study.
Jahr JS; Liu H; Albert OK; Gull A; Moallempour M; Lim J; Gosselin R
Am J Ther; 2010; 17(2):140-7. PubMed ID: 19417588
[TBL] [Abstract][Full Text] [Related]
14. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
[TBL] [Abstract][Full Text] [Related]
15. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
16. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial.
Sprung J; Kindscher JD; Wahr JA; Levy JH; Monk TG; Moritz MW; O'Hara PJ
Anesth Analg; 2002 Apr; 94(4):799-808, table of contents. PubMed ID: 11916776
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.
Baumann BC; Stussi G; Huggel K; Rieben R; Seebach JD
Transplantation; 2007 Jan; 83(2):193-201. PubMed ID: 17264816
[TBL] [Abstract][Full Text] [Related]
18. Validation of oxygen saturation measurements in a canine model of hemoglobin based oxygen carrier (HBOC) infusion.
Jahr JS; Lurie F; Driessen B; Tang Z; Louie RF; Kullar R; Kost G
Clin Lab Sci; 2000; 13(2):173-9. PubMed ID: 14989329
[TBL] [Abstract][Full Text] [Related]
19. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies.
Long C; Hara H; Pawlikowski Z; Koike N; d'Arville T; Yeh P; Ezzelarab M; Ayares D; Yazer M; Cooper DK
Transfusion; 2009 Nov; 49(11):2418-29. PubMed ID: 19624491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
